The Role of Amyloid PET in Diagnosing Possible Transmissible Cerebral Amyloid Angiopathy in Young Adults with a History of Neurosurgery: A Case Series

Cerebrovasc Dis. 2021;50(3):356-360. doi: 10.1159/000514139. Epub 2021 Mar 19.

Abstract

Background: Cerebral amyloid angiopathy (CAA) is a common cause of cerebrovascular disease in the elderly. There is accumulating evidence suggestive of transmissibility of β-amyloid resulting in amyloid pathology at younger age. According to the Boston criteria, defining CAA in patients <55 years requires histological evidence which may hamper diagnosis. We explored the role of amyloid PET in the diagnosis of possible transmissible CAA in young adults.

Cases: We report 4 young adults (<55 years) presenting with clinical and neuroimaging features suggestive of CAA but without genetic evidence of hereditary CAA explaining the young onset. A common factor in all cases was a medical history of neurosurgery during childhood. All patients underwent amyloid PET to support the diagnosis of an amyloid-related pathology and the result was positive in all 4.

Conclusion: Combining the clinical presentation and imaging findings of the 4 cases, we postulate transmissible CAA as the possible diagnosis. Further epidemiological studies are required to gain more insight in the prevalence of this novel entity. Amyloid PET may be a useful, non-invasive tool in these analyses especially since pathological evidence will be lacking in most of these studies.

Keywords: Amyloid PET; Cerebral amyloid angiopathy; Cerebral hemorrhage; Cerebrovascular disease; Neurosurgery.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amyloid beta-Peptides / metabolism*
  • Aniline Compounds
  • Biomarkers / metabolism
  • Brain / diagnostic imaging*
  • Brain / metabolism
  • Cerebral Amyloid Angiopathy / diagnostic imaging*
  • Cerebral Amyloid Angiopathy / metabolism
  • Contrast Media
  • Humans
  • Male
  • Middle Aged
  • Neuroimaging*
  • Neurosurgical Procedures / adverse effects*
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Risk Factors
  • Thiazoles

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Biomarkers
  • Contrast Media
  • Thiazoles